Circulating Tumor Cells as Biomarkers in Pancreatic Cancer

[1]  K. Pantel,et al.  Liquid biopsy and minimal residual disease — latest advances and implications for cure , 2019, Nature Reviews Clinical Oncology.

[2]  M. Speicher,et al.  Current and future perspectives of liquid biopsies in genomics-driven oncology , 2018, Nature Reviews Genetics.

[3]  Min Yu,et al.  Circulating tumor cells as "liquid biopsies" to understand cancer metastasis. , 2018, Translational research : the journal of laboratory and clinical medicine.

[4]  M. Makary,et al.  Circulating Tumor Cells Dynamics in Pancreatic Adenocarcinoma Correlate With Disease Status: Results of the Prospective CLUSTER Study , 2018, Annals of surgery.

[5]  J. Tomlinson,et al.  Pancreatic cancer circulating tumor cells: applications for personalized oncology , 2018, Expert review of molecular diagnostics.

[6]  P. Chand,et al.  Evaluation of Immunohistochemical Profile of Breast Cancer for Prognostics and Therapeutic Use , 2018, Nigerian journal of surgery : official publication of the Nigerian Surgical Research Society.

[7]  E. Sabo,et al.  Mutant KRAS Circulating Tumor DNA Is an Accurate Tool for Pancreatic Cancer Monitoring. , 2018, The oncologist.

[8]  Ling Wang,et al.  An integrated flow cytometry-based platform for isolation and molecular characterization of circulating tumor single cells and clusters , 2018, Scientific Reports.

[9]  Ludmila V. Danilova,et al.  Detection and localization of surgically resectable cancers with a multi-analyte blood test , 2018, Science.

[10]  L. Arendt-Nielsen,et al.  A Comparison of Oral Sensory Effects of Three TRPA1 Agonists in Young Adult Smokers and Non-smokers , 2017, Front. Physiol..

[11]  M. Makary,et al.  Combined circulating tumor DNA and protein biomarker-based liquid biopsy for the earlier detection of pancreatic cancers , 2017, Proceedings of the National Academy of Sciences.

[12]  S. Pandol,et al.  The Potential for Circulating Tumor Cells in Pancreatic Cancer Management , 2017, Front. Physiol..

[13]  D. Dransfield,et al.  CTC-mRNA (AR-V7) Analysis from Blood Samples—Impact of Blood Collection Tube and Storage Time , 2017, International journal of molecular sciences.

[14]  J. Cameron,et al.  Patterns, Timing, and Predictors of Recurrence Following Pancreatectomy for Pancreatic Ductal Adenocarcinoma , 2017, Annals of surgery.

[15]  Lynne Penberthy,et al.  Cancer Incidence and Survival Trends by Subtype Using Data from the Surveillance Epidemiology and End Results Program, 1992–2013 , 2016, Cancer Epidemiology, Biomarkers & Prevention.

[16]  J. Cameron,et al.  Circulating Tumor Cell Phenotype Predicts Recurrence and Survival in Pancreatic Adenocarcinoma , 2016, Annals of surgery.

[17]  T. Graeber,et al.  Reality of Single Circulating Tumor Cell Sequencing for Molecular Diagnostics in Pancreatic Cancer. , 2016, The Journal of molecular diagnostics : JMD.

[18]  N. Aceto,et al.  Stem-like features of cancer cells on their way to metastasis , 2016, Biology Direct.

[19]  C. Iacobuzio-Donahue,et al.  Pancreatic cancer biology and genetics from an evolutionary perspective , 2016, Nature Reviews Cancer.

[20]  A. Warshaw,et al.  KRAS mutations in pancreatic circulating tumor cells: a pilot study , 2016, Tumor Biology.

[21]  Christine A Iacobuzio-Donahue,et al.  Genotype tunes pancreatic ductal adenocarcinoma tissue tension to induce matricellular-fibrosis and tumor progression , 2016, Nature Medicine.

[22]  M R Speicher,et al.  The biology of circulating tumor cells , 2016, Oncogene.

[23]  R. Gibbs,et al.  Genomic analyses identify molecular subtypes of pancreatic cancer , 2016, Nature.

[24]  J. Massagué,et al.  Metastatic colonization by circulating tumour cells , 2016, Nature.

[25]  J. Fort,et al.  A mathematical approach to virus therapy of glioblastomas , 2016, Biology Direct.

[26]  Minetta C. Liu,et al.  Circulating tumor cells are associated with poor overall survival in patients with cholangiocarcinoma , 2016, Hepatology.

[27]  Jen Jen Yeh,et al.  Virtual microdissection identifies distinct tumor- and stroma-specific subtypes of pancreatic ductal adenocarcinoma , 2015, Nature Genetics.

[28]  K. Lillemoe,et al.  Circulating Epithelial Cells in Patients with Pancreatic Lesions: Clinical and Pathologic Findings. , 2015, Journal of the American College of Surgeons.

[29]  R. Chojniak,et al.  Detection of KRAS mutations in circulating tumor cells from patients with metastatic colorectal cancer , 2015, Cancer biology & therapy.

[30]  V. Servois,et al.  Circulating tumor cell thresholds and survival scores in advanced metastatic breast cancer: the observational step of the CirCe01 phase III trial. , 2015, Cancer letters.

[31]  N. Gusani,et al.  Circulating tumor cell isolation during resection of colorectal cancer lung and liver metastases: a prospective trial with different detection techniques , 2015, Cancer biology & therapy.

[32]  I. Vermes,et al.  Importance of circulating tumor cells in newly diagnosed colorectal cancer. , 2015, International journal of oncology.

[33]  Donghong Zhang,et al.  Patterns of circulating tumor cells identified by CEP8, CK and CD45 in pancreatic cancer , 2015, International journal of cancer.

[34]  J. Kench,et al.  Whole genomes redefine the mutational landscape of pancreatic cancer , 2015, Nature.

[35]  Robert B Livingston,et al.  Circulating tumor cells and response to chemotherapy in metastatic breast cancer: SWOG S0500. , 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[36]  Hui Jiang,et al.  Expansion of CTCs from early stage lung cancer patients using a microfluidic co-culture model , 2014, Oncotarget.

[37]  Sridhar Ramaswamy,et al.  Circulating Tumor Cell Clusters Are Oligoclonal Precursors of Breast Cancer Metastasis , 2014, Cell.

[38]  K. Pantel,et al.  Challenges in circulating tumour cell research , 2014, Nature Reviews Cancer.

[39]  S. Sun,et al.  Treatment of patients with gestational trophoblastic neoplasia (GTN) in 12 South America referral centers: Results after 10 years since international FIGO consensus. , 2014 .

[40]  Aviv Regev,et al.  Whole exome sequencing of circulating tumor cells provides a window into metastatic prostate cancer , 2014, Nature Biotechnology.

[41]  A. Krešo,et al.  Evolution of the cancer stem cell model. , 2014, Cell stem cell.

[42]  Qicheng Zhao,et al.  Prognostic value of circulating tumor cells in patients with pancreatic cancer: a meta-analysis , 2014, Tumor Biology.

[43]  D. Massi,et al.  Circulating Tumor Cells Detection and Counting in Uveal Melanomas by a Filtration-Based Method , 2014, Cancers.

[44]  X. Xie,et al.  Reproducible copy number variation patterns among single circulating tumor cells of lung cancer patients , 2013, Proceedings of the National Academy of Sciences.

[45]  J. Massagué,et al.  Review Origins of Metastatic Traits , 2022 .

[46]  T. Fehm,et al.  Diagnostic leukapheresis enables reliable detection of circulating tumor cells of nonmetastatic cancer patients , 2013, Proceedings of the National Academy of Sciences.

[47]  F. Bidard,et al.  Circulating tumor cells in locally advanced pancreatic adenocarcinoma: the ancillary CirCe 07 study to the LAP 07 trial. , 2013, Annals of oncology : official journal of the European Society for Medical Oncology.

[48]  P. Fortina,et al.  Circulating tumor DNA to monitor metastatic breast cancer. , 2013, The New England journal of medicine.

[49]  Peter Ulz,et al.  Complex tumor genomes inferred from single circulating tumor cells by array-CGH and next-generation sequencing. , 2013, Cancer research.

[50]  A. Dirican,et al.  Prognostic significance of circulating tumor cells and serum CA15-3 levels in metastatic breast cancer, single center experience, preliminary results. , 2013, Asian Pacific journal of cancer prevention : APJCP.

[51]  M A Firpo,et al.  The clinical utility of CA 19-9 in pancreatic adenocarcinoma: diagnostic and prognostic updates. , 2013, Current molecular medicine.

[52]  Sheng Pan,et al.  Tissue proteomics in pancreatic cancer study: Discovery, emerging technologies, and challenges , 2013, Proteomics.

[53]  Sridhar Ramaswamy,et al.  Circulating Breast Tumor Cells Exhibit Dynamic Changes in Epithelial and Mesenchymal Composition , 2013, Science.

[54]  C. Punt,et al.  Relationship among circulating tumor cells, CEA and overall survival in patients with metastatic colorectal cancer. , 2013, Annals of oncology : official journal of the European Society for Medical Oncology.

[55]  C. Punt,et al.  Relationship among circulating tumor cells, CEA and overall survival in patients with metastatic colorectal cancer. , 2013, Annals of oncology : official journal of the European Society for Medical Oncology.

[56]  H. Groen,et al.  Circulating tumor cells in small-cell lung cancer: a predictive and prognostic factor. , 2012, Annals of oncology : official journal of the European Society for Medical Oncology.

[57]  H. Groen,et al.  Circulating tumor cells in small-cell lung cancer: a predictive and prognostic factor. , 2012 .

[58]  I. Vermes,et al.  Circulating tumor cells, disease recurrence and survival in newly diagnosed breast cancer , 2012, Breast Cancer Research.

[59]  Tao Wang,et al.  Meta-Analysis of the Prognostic Value of Circulating Tumor Cells in Breast Cancer , 2012, Clinical Cancer Research.

[60]  M. Cristofanilli,et al.  Circulating tumor cells (CTCs) in breast cancer: a diagnostic tool for prognosis and molecular analysis , 2012 .

[61]  H. Kuerer,et al.  Circulating tumour cells in non-metastatic breast cancer: a prospective study. , 2012, The Lancet. Oncology.

[62]  Sridhar Ramaswamy,et al.  RNA sequencing of pancreatic circulating tumour cells implicates WNT signaling in metastasis , 2012, Nature.

[63]  K. Pantel,et al.  Circulating epithelial cells in patients with benign colon diseases. , 2012, Clinical chemistry.

[64]  Caroline Dive,et al.  Clinical significance and molecular characteristics of circulating tumor cells and circulating tumor microemboli in patients with small-cell lung cancer. , 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[65]  Sepp Kaul,et al.  Multimarker Gene Analysis of Circulating Tumor Cells in Pancreatic Cancer Patients: A Feasibility Study , 2012, Oncology.

[66]  Maximilian Reichert,et al.  EMT and Dissemination Precede Pancreatic Tumor Formation , 2012, Cell.

[67]  D. Planchard,et al.  Detection of circulating tumour cells with a hybrid (epithelial/mesenchymal) phenotype in patients with metastatic non-small cell lung cancer , 2011, British Journal of Cancer.

[68]  T. Molina,et al.  Detection of circulating tumor cells as a prognostic factor in patients undergoing radical surgery for non‐small‐cell lung carcinoma: comparison of the efficacy of the CellSearch Assay™ and the isolation by size of epithelial tumor cell method , 2011, International journal of cancer.

[69]  L. Fink,et al.  Circulating tumor cells as a predictive biomarker in patients with hormone-sensitive prostate cancer. , 2011, Clinical genitourinary cancer.

[70]  Andrew J Armstrong,et al.  Angiogenesis , Metastasis , and the Cellular Microenvironment Circulating Tumor Cells from Patients with Advanced Prostate and Breast Cancer Display Both Epithelial and Mesenchymal Markers , 2011 .

[71]  S. Agelaki,et al.  Epithelial to mesenchymal transition markers expressed in circulating tumour cells of early and metastatic breast cancer patients , 2011, Breast Cancer Research.

[72]  P. Spellman,et al.  Subtypes of Pancreatic Ductal Adenocarcinoma and Their Differing Responses to Therapy , 2011, Nature Medicine.

[73]  R. Hruban,et al.  Tumour epithelial vimentin expression and outcome of pancreatic ductal adenocarcinomas , 2011, British Journal of Cancer.

[74]  Caroline Dive,et al.  Circulating tumor cells as a window on metastasis biology in lung cancer. , 2011, The American journal of pathology.

[75]  T. Molina,et al.  Preoperative Circulating Tumor Cell Detection Using the Isolation by Size of Epithelial Tumor Cell Method for Patients with Lung Cancer Is a New Prognostic Biomarker , 2010, Clinical Cancer Research.

[76]  R. Huang,et al.  Epithelial-Mesenchymal Transitions in Development and Disease , 2009, Cell.

[77]  David Allard,et al.  Inhibition of Hedgehog Signaling Enhances Delivery of Chemotherapy in a Mouse Model of Pancreatic Cancer , 2009, Science.

[78]  G. Parmigiani,et al.  Core Signaling Pathways in Human Pancreatic Cancers Revealed by Global Genomic Analyses , 2008, Science.

[79]  A. Puisieux,et al.  Generation of Breast Cancer Stem Cells through Epithelial-Mesenchymal Transition , 2008, PloS one.

[80]  Mehmet Toner,et al.  Detection of mutations in EGFR in circulating lung-cancer cells. , 2008, The New England journal of medicine.

[81]  Michael Morse,et al.  Relationship of circulating tumor cells to tumor response, progression-free survival, and overall survival in patients with metastatic colorectal cancer. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[82]  D. Simeone,et al.  Pancreatic cancer stem cells. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[83]  Wenjun Guo,et al.  The Epithelial-Mesenchymal Transition Generates Cells with Properties of Stem Cells , 2008, Cell.

[84]  Jaw-Yuan Wang,et al.  Persistent Presence of Postoperative Circulating Tumor Cells is a Poor Prognostic Factor for Patients with Stage I–III Colorectal Cancer after Curative Resection , 2008, Annals of Surgical Oncology.

[85]  F. Itokawa,et al.  Detection of circulating tumor cells in patients with pancreatic cancer: a preliminary result. , 2008, Journal of hepato-biliary-pancreatic surgery.

[86]  S. Digumarthy,et al.  Isolation of rare circulating tumour cells in cancer patients by microchip technology , 2007, Nature.

[87]  A. Siriwardena,et al.  Systematic review of carbohydrate antigen (CA 19-9) as a biochemical marker in the diagnosis of pancreatic cancer. , 2007, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[88]  Brigitte Rack,et al.  Detection of Circulating Tumor Cells in Peripheral Blood of Patients with Metastatic Breast Cancer: A Validation Study of the CellSearch System , 2007, Clinical Cancer Research.

[89]  Thomas Kirchner,et al.  Migrating cancer stem cells — an integrated concept of malignant tumour progression , 2005, Nature Reviews Cancer.

[90]  Tanja Fehm,et al.  Circulating Tumor Cells in Patients with Breast Cancer Dormancy , 2004, Clinical Cancer Research.

[91]  Alison Stopeck,et al.  Circulating tumor cells, disease progression, and survival in metastatic breast cancer. , 2004, The New England journal of medicine.

[92]  Christine A Iacobuzio-Donahue,et al.  Exploration of global gene expression patterns in pancreatic adenocarcinoma using cDNA microarrays. , 2003, The American journal of pathology.

[93]  F. Hirsch,et al.  HER2/neu expression in malignant lung tumors. , 2002, Seminars in oncology.

[94]  M. Tempero,et al.  Relationship of carbohydrate antigen 19-9 and Lewis antigens in pancreatic cancer. , 1987, Cancer research.

[95]  S. Eghbali,et al.  Deploying Immunotherapy in Pancreatic Cancer: Defining Mechanisms of Response and Resistance. , 2017, American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting.

[96]  Xuelei Ma,et al.  Prognostic role of circulating tumor cells in patients with pancreatic cancer: a meta-analysis. , 2014, Asian Pacific journal of cancer prevention : APJCP.

[97]  M. Cristofanilli,et al.  Circulating tumor cells (CTCs) in breast cancer: a diagnostic tool for prognosis and molecular analysis. , 2012, Chinese journal of cancer research = Chung-kuo yen cheng yen chiu.

[98]  Jian Tu,et al.  A higher number of circulating tumor cells (CTC) in peripheral blood indicates poor prognosis in prostate cancer patients--a meta-analysis. , 2011, Asian Pacific journal of cancer prevention : APJCP.

[99]  R. Hruban,et al.  Exploring the host desmoplastic response to pancreatic carcinoma: gene expression of stromal and neoplastic cells at the site of primary invasion. , 2002, The American journal of pathology.

[100]  K. Schütze,et al.  Isolation by size of epithelial tumor cells : a new method for the immunomorphological and molecular characterization of circulatingtumor cells. , 2000, The American journal of pathology.